XML 69 R70.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Reporting - Retrospective Adjustment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Segment Reporting Information [Line Items]        
Total revenues $ 64,810 $ 47,490 $ 189,887 $ 140,155
Cost of products sold 40,437 39,502 116,654 115,883
Benefit costs 12,850 439 39,396 2,399
Operating expenses 8,595 4,975 24,887 14,755
Operating income (GAAP measure) 2,928 2,574 8,950 3,197
Adjusted operating income (loss) 3,947 2,650 11,573 7,542
Operating Segments | Pharmacy Services Segment        
Segment Reporting Information [Line Items]        
Total revenues 36,018 33,864 104,418 99,837
Cost of products sold   32,238   95,518
Benefit costs   0   0
Operating expenses   351   1,051
Operating income (GAAP measure)   1,275   3,268
Adjusted operating income (loss) 1,439 1,362 3,682 3,530
Operating Segments | Retail Long-Term Care Segment        
Segment Reporting Information [Line Items]        
Total revenues 21,466 20,856 64,028 61,960
Cost of products sold   15,042   44,318
Benefit costs   0   0
Operating expenses   4,323   12,831
Operating income (GAAP measure)   1,491   890
Adjusted operating income (loss) 1,516 1,622 4,674 5,279
Operating Segments | Health Care Benefits Segment        
Segment Reporting Information [Line Items]        
Total revenues 17,181 641 52,454 2,723
Cost of products sold   0   0
Benefit costs   439   2,399
Operating expenses   128   388
Operating income (GAAP measure)   74   (64)
Adjusted operating income (loss) 1,423 75 4,423 (62)
Operating Segments | Corporate / Other        
Segment Reporting Information [Line Items]        
Total revenues 152 217 423 475
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   287   814
Operating income (GAAP measure)   (70)   (339)
Adjusted operating income (loss) (252) (213) (685) (647)
Intersegment Eliminations        
Segment Reporting Information [Line Items]        
Total revenues (10,007) (8,088) (31,436) (24,840)
Cost of products sold   (7,778)   (23,953)
Benefit costs   0   0
Operating expenses   (114)   (329)
Operating income (GAAP measure)   (196)   (558)
Adjusted operating income (loss) $ (179) (196) $ (521) (558)
Previously Reported        
Segment Reporting Information [Line Items]        
Total revenues   47,490   140,155
Cost of products sold   39,502   115,883
Benefit costs   439   2,399
Operating expenses   4,975   14,755
Operating income (GAAP measure)   2,574   3,197
Previously Reported | Operating Segments | Pharmacy Services Segment        
Segment Reporting Information [Line Items]        
Total revenues   33,767   99,238
Cost of products sold   31,587   92,459
Benefit costs   439   2,399
Operating expenses   392   1,176
Operating income (GAAP measure)   1,349   3,204
Previously Reported | Operating Segments | Retail Long-Term Care Segment        
Segment Reporting Information [Line Items]        
Total revenues   20,856   61,960
Cost of products sold   15,042   44,318
Benefit costs   0   0
Operating expenses   4,323   12,831
Operating income (GAAP measure)   1,491   890
Previously Reported | Operating Segments | Health Care Benefits Segment        
Segment Reporting Information [Line Items]        
Total revenues   0   0
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   0   0
Operating income (GAAP measure)   0   0
Previously Reported | Operating Segments | Corporate / Other        
Segment Reporting Information [Line Items]        
Total revenues   217   475
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   287   814
Operating income (GAAP measure)   (70)   (339)
Previously Reported | Intersegment Eliminations        
Segment Reporting Information [Line Items]        
Total revenues   (7,350)   (21,518)
Cost of products sold   (7,127)   (20,894)
Benefit costs   0   0
Operating expenses   (27)   (66)
Operating income (GAAP measure)   (196)   (558)
Restatement Adjustment        
Segment Reporting Information [Line Items]        
Total revenues   0   0
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   0   0
Operating income (GAAP measure)   0   0
Adjusted operating income (loss)   76   4,345
Restatement Adjustment | Operating Segments | Pharmacy Services Segment        
Segment Reporting Information [Line Items]        
Total revenues   97   599
Cost of products sold   651   3,059
Benefit costs   (439)   (2,399)
Operating expenses   (41)   (125)
Operating income (GAAP measure)   (74)   64
Adjusted operating income (loss)   87   262
Restatement Adjustment | Operating Segments | Retail Long-Term Care Segment        
Segment Reporting Information [Line Items]        
Total revenues   0   0
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   0   0
Operating income (GAAP measure)   0   0
Adjusted operating income (loss)   131   4,389
Restatement Adjustment | Operating Segments | Health Care Benefits Segment        
Segment Reporting Information [Line Items]        
Total revenues   641   2,723
Cost of products sold   0   0
Benefit costs   439   2,399
Operating expenses   128   388
Operating income (GAAP measure)   74   (64)
Adjusted operating income (loss)   1   2
Restatement Adjustment | Operating Segments | Corporate / Other        
Segment Reporting Information [Line Items]        
Total revenues   0   0
Cost of products sold   0   0
Benefit costs   0   0
Operating expenses   0   0
Operating income (GAAP measure)   0   0
Adjusted operating income (loss)   (143)   (308)
Restatement Adjustment | Intersegment Eliminations        
Segment Reporting Information [Line Items]        
Total revenues   (738)   (3,322)
Cost of products sold   (651)   (3,059)
Benefit costs   0   0
Operating expenses   (87)   (263)
Operating income (GAAP measure)   0   0
Adjusted operating income (loss)   $ 0   $ 0